Navigation Links
Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results
Date:2/27/2008

ollaborative agreement, net, is comprised of

the following (in thousands):

Three and Twelve-Months

Ended December 31, 2007

Pfizer termination settlement

payment received 135,000

Exubera Inhaler Manufacturing and

Supply Agreement Termination

Tech Group (13,765)

Bespak (18,598)

102,637

Settlement of assets and

liabilities related to Pfizer (23,459)

Gain on termination of

collaborative agreements, net 79,178

(3) For the three-months ended December 31, 2007, there were

approximately 578 dilutive shares which did not change earnings per

share.

NEKTAR THERAPEUTICS

CONSOLIDATED BALANCE SHEETS

(In thousands)

(unaudited)

ASSETS December 31, 2007 December 31, 2006(1)

Current assets:

Cash and cash equivalents $76,293 $63,760

Short-term investments 406,060 394,880

Accounts receivable, net of

allowance 21,637 47,148

Inventory 12,187 14,656

Other current assets 7,106 14,595

Total current assets 523,283 535,039

Long-term investments - 8,337

Property and equipment, net
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Nektar to Announce Third Quarter 2007 Financial Results on Wednesday, November 7, 2007, After the Close of U.S. Financial Markets
2. Nektar Therapeutics Announces Third Quarter 2007 Financial Results
3. Nektars Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York
4. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
5. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
6. Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets
7. Prime Therapeutics Receives TIPPS Certification
8. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
9. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
10. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
11. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Vivakor Announces New Acquisition Strategy 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Helix BioPharma Reports On 2009 Annual General Meeting 2Helix BioPharma Reports On 2009 Annual General Meeting 3New Shocking Documentary on Lyme Disease 26apos 3BUnder the Eightball 26apos 3B to Premiere at Michael Moore 26apos 3Bs State Theater in Traverse Cit 54938 1New Shocking Documentary on Lyme Disease 26apos 3BUnder the Eightball 26apos 3B to Premiere at Michael Moore 26apos 3Bs State Theater in Traverse Cit 54938 2Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 1Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 2Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 3Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 4Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 5Most Americans Continue to Support Moving Ahead With Health Care Reform Now Despite Town Hall Fights and Ad Campaigns 54934 6President Obama Misleads on Abortion Funding in Health Care Reform 54931 1President Obama Misleads on Abortion Funding in Health Care Reform 54931 2